Mpox (Monkeypox) Clinical Trials

27 clinical trials for Mpox (Monkeypox) across international registries, including 9 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Randomized Clinical Trial Investigating the Safety, Reactogenicity, and Immunogenicity After Immunization With an mRNA-based Mpox Vaccine Candidate in Africa — RECRUITING · PHASE2
• Smart Analysis and Decision-Making for Emerging Infectious Diseases — RECRUITING · NA
• Validation of SDS-EDTA-Treated Chromatography Paper Strips for Mpox Sampling and Transport in DRC — RECRUITING
• New York City Observational Study of Mpox Immunity — RECRUITING
• Epidemiological and Clinical Characteristics of Mpox Outbreak in Equateur, the DR Congo (Part1) — RECRUITING
• Epidemiological and Clinical Characteristics of Human Mpox Outbreak in Equateur Province in the Democratic Republic of Congo (Part3) — RECRUITING
• Mpox Comprehensive Assessment for Responsive Immunisation in Emergency Outbreaks — RECRUITING · NA
• Mpox Biology, Outcome, Transmission and Epidemiology — RECRUITING
• Observational, Prospective, Cohort Study of Mpox Infection in Brazil (NETPOX) — RECRUITING
• Study of Tecovirimat for Human Mpox Virus — TERMINATED · PHASE3
• Mpox Biology, Outcome, Transmission and Epidemiology - Tracking the Immune Response After mpoX vaCcination (MBOTE-TRAXX): Clinical Study to Monitor the Immunological Response Following Mpox Vaccination in the City of Kinshasa, Democratic Republic of the Congo — ACTIVE_NOT_RECRUITING · PHASE4
• Assessment of the Efficacy and Safety of Tecovirimat in Patients With Monkeypox Virus Disease — ACTIVE_NOT_RECRUITING · PHASE3
• An Immunogenicity and Safety Trial of MVA-BN in Adults Living With HIV for the Prevention of Mpox Infection, in Kinshasa, DRC — ACTIVE_NOT_RECRUITING · PHASE2
• Assessment of Immune Memory - Humoral and Cellular - in mPOX-infected Patients : an Ancillary Study of the ANRS0258s MOSAIC Cohort — NOT_YET_RECRUITING · NA
• Investigating MPXV Viral Clearance in Mpox Cases and Secondary Attack Rate in Contacts — COMPLETED
• Phase 3 Infant Safety & Immunogenicity Trial of MVA-BN® in DRC — ACTIVE_NOT_RECRUITING · PHASE3
• Understanding MPXV Viral Clearance, Transmission Dynamics, and Mpox Vaccine Effectiveness in West Africa : Guinea — NOT_YET_RECRUITING
• Ocular Complications of Mpox in the Democratic Republic Congo — COMPLETED
• Immunogenicity and safety of a fractional subcutaneous booster booster vaccination against mpox with MVA-BN: a randomised-controlled non-inferiority study (SUBO-trial) — TERMINATED · PHASE3
• Phase 3 Maternal Safety & Immunogenicity Trial of MVA-BN® in DRC — ACTIVE_NOT_RECRUITING · PHASE3
• Evaluation of Effectiveness and Safety of LC16m8 Mpox Vaccine in the Democratic Republic of Congo (DRC) — NOT_YET_RECRUITING
• Tecovirimat for Treatment of Monkeypox Virus - Study Extension Providing Standard of Care Only — COMPLETED
• A Study to Investigate The Safety, Tolerability, And Immune Response of a Range of Doses of mRNA-1769 Compared With Placebo in Healthy Participants From ≥18 Years of Age to <50 Years of Age — COMPLETED · PHASE1
• Monkeypox, Biology, Outcome, Transmission and Epidemiology -Prospective Follow-up of High-risk Contacts — COMPLETED
• DiagRaMIE Mpox Virus-RDC for the Diagnostic of Monkeypox — NOT_YET_RECRUITING
• Break-through Infection Following Mpox vaccinatIon — COMPLETED
• Looking for Asymptomatic Mpox in a Population at High Risk — OTHER

Refine this search